Drug Trial Radar · NCT07478848
Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas
Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
14
Planned (sponsor's estimate)
Start
May 29, 2026
Primary completion
Jan 1, 2029
Study completion Jan 1, 2029
Sponsor
- Lead sponsor
- Abramson Cancer Center at Penn MedicineAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Mar 18, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This clinical trial assesses whether it is feasible to use radiation therapy with vancomycin prior to CAR T-cell therapy for patients with large B-cell lymphomas
Conditions
- Large B Cell Lymphoma
- Non Hodgkin Lymphoma (NHL)
- Diffuse Large B Cell Lymphoma (DLBCL)
- Diffuse Large B Cell Lymphoma Refractory
- Diffuse Large B Cell Lymphoma Relapsed
Interventions
Vancomycin 125mgDrug
oral
Radiation TherapyRadiation
Radiation Therapy
CAR-TBiological
standard of care anti-CD19 CAR-T
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cytokine release syndromeTime frame: date of CAR-T infusion to 28 days after infusion
- Severe adverse eventsTime frame: CAR-T infusion to 28 days after infusion
- VRETime frame: start of vancomycin to day 28 after CAR-T infusion
- Adverse EventsTime frame: start of vancomycin until day 28 after CAR-T infusion
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Abramson Cancer Center, University of Pennsylvania
Philadelphia, Pennsylvania · Recruiting
Huntsman Cancer Institute, University of Utah
Salt Lake City, Utah · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.